Amount of systemic steroid medication is a strong predictor for the use of complementary and alternative medicine in patients with inflammatory bowel disease -: Results from a German national survey

被引:87
|
作者
Langhorst, J
Anthonisen, IB
Steder-Neukamm, U
Lüdtke, R
Spahn, G
Michalsen, A
Dobos, GJ
机构
[1] Kliniken Essen Mitte, Dept Internal Med, D-45276 Essen, Germany
[2] Univ Duisburg Essen, Dept Gastroenterol & Hepatol, Duisburg, Germany
[3] German Crohns & Ulcerat Colitis Assoc, Leverkusen, Germany
[4] Karl & Veronica Carstens Fdn, Essen, Germany
关键词
alternative medicine; complementary medicine; Crohn's disease; ulcerative colitis;
D O I
10.1097/01.MIB.0000160771.71328.6c
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objectives: Previous studies have suggested that inflammatory bowel disease (IBD) patients rank high among users of complementary and alternative medicine (CAM). To further elucidate this phenomenon, we sent questionnaires to a large sample of IBD patients in Germany to determine the patterns and predictors of their CAM use. Methods: Pretested 73-item questionnaires were mailed to a randomly selected representative sample of 1000 1 BD patients from the approximately 16,000 members and associates of the German Crohn's and Colitis Association. Predictors of CAM use were evaluated by logistic regression models. Results: Completed questionnaires were returned by 684 patients (female patients, 61.4%; Crohn's disease patients, 58.3%; ulcerative colitis patients, 38.2%). Of the 671 adult respondents, 344 (51.3%) had experience with CAM, and significantly more of the ulcerative colitis patients (59.8%) than the Crohn's disease patients (48.3%) had experience with CAM. There was no difference by gender. Homeopathy (52.9%) and herbal medicine (43.6%) were the most commonly used types of CAM. The most frequent personal reasons for CAM use were the search for an "optimum treatment" (78.9%) and the wish to stop taking steroids (63.8%). Using logistic regression, we found that total cortisone intake (P = 0.0077), but not duration of disease, was a strong predictor of CAM use. Other predictors were experience with psychosomatic and psychotherapeutic support (P = 0.0029), relaxation techniques (P = 0.0284), an academic education (P = 0.0173), a diet utilizing whole grains (P = 0.0123), and a normal body weight (P = 0.0215). Although 80% of patients indicated that they were interested in using CAM in the future, only 24.7% felt sufficiently informed about it. Conclusions: More than 50% of a large group of German IBD patients had used CAM. Prolonged or intensive steroid treatment, an academic education, active ways of coping, and a health-conscious life-style are associated with CAM use. Given the potential side effects and interactions, the treating physician should focus on thorough information about the benefits and limitations of conventional and complementary treatment options, especially for IBD patients who have received prolonged or intensive steroid treatment.
引用
收藏
页码:287 / 295
页数:9
相关论文
共 50 条
  • [21] Complementary and alternative medicine use in adolescents with inflammatory bowel disease and juvenile idiopathic arthritis
    Nousiainen, Pauliina
    Merras-Salmio, Laura
    Aalto, Kristiina
    Kolho, Kaija-Leena
    BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2014, 14
  • [22] Complementary and alternative medicine use in adolescents with inflammatory bowel disease and juvenile idiopathic arthritis
    Pauliina Nousiainen
    Laura Merras-Salmio
    Kristiina Aalto
    Kaija-Leena Kolho
    BMC Complementary and Alternative Medicine, 14
  • [23] Complementary and Alternative Medicine Use in Children With Inflammatory Bowel Diseases: A Single-Center Survey
    Serpico, Mark R.
    Boyle, Brendan M.
    Kemper, Kathi J.
    Kim, Sandra C.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2016, 63 (06) : 651 - 657
  • [24] The Use of Complementary and Alternative Medicine among Patients with Inflammatory Bowel Disease Is Associated with Reduced Health-Related Quality of Life
    Opheim, Randi
    Hoivik, Marte Lie
    Bernklev, Tomm
    Jelsness-Jorgensen, Lars-Petter
    Moum, Bjorn
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2016, 2016
  • [25] Use of Complementary and Alternative Medicine for Inflammatory Bowel Disease Is Associated with Worse Adherence to Conventional Therapy: The COMPLIANT Study
    Nguyen, Geoffrey C.
    Croitoru, Ken
    Silverberg, Mark S.
    Steinhart, A. Hillary
    Weizman, Adam V.
    INFLAMMATORY BOWEL DISEASES, 2016, 22 (06) : 1412 - 1417
  • [26] Complementary and alternative medicine in patients with inflammatory bowel disease: The results of a population-based inception cohort study (IBSEN)
    Opheim, Randi
    Hoivik, Marte L.
    Solberg, Inger C.
    Moum, Bjorn
    JOURNAL OF CROHNS & COLITIS, 2012, 6 (03) : 345 - 353
  • [27] Use and Predictors of Oral Complementary and Alternative Medicine by Patients With Inflammatory Bowel Disease: A Population-Based, Case-Control Study
    Koning, Marije
    Ailabouni, Ramez
    Gearry, Richard B.
    Frampton, Christopher M. A.
    Barclay, Murray L.
    INFLAMMATORY BOWEL DISEASES, 2013, 19 (04) : 767 - 778
  • [28] Patterns of Complementary and Alternative Medicine Use in Saudi Arabian Patients With Inflammatory Bowel Disease: A Cross-Sectional Study
    Altunisi, Albaraa, Jr.
    Mosli, Mahmoud
    Banweer, Mazen
    Qari, Yousif
    Arif, Faris O.
    Saadah, Omar, I
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (08)
  • [29] The Use of Complementary and Alternative Medicine Is Less Frequent in Patients with Inflammatory Bowel Disease Than in Patients with Other Chronic Gastrointestinal Disorders
    Fabian, Anna
    Rutka, Mariann
    Ferenci, Tamas
    Bor, Renata
    Balint, Anita
    Farkas, Klaudia
    Milassin, Agnes
    Szanto, Kata
    Lenart, Zsuzsanna
    Nagy, Ferenc
    Szepes, Zoltan
    Molnar, Tamas
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2018, 2018
  • [30] Use of complementary and alternative medicine and low quality of life associate with the need for psychological and psychotherapeutic interventions in inflammatory bowel disease
    Kutschera, Maximilian
    Waldhoer, Thomas
    Groechenig, Hans Peter
    Haas, Thomas
    Wenzl, Heimo
    Steiner, Pius
    Koch, Robert
    Feichtenschlager, Thomas
    Eckhardt, Gerald
    Mayer, Andreas
    Kirchgatterer, Andreas
    Ludwiczek, Othmar
    Platzer, Reingard
    Papay, Pavot
    Gartner, Johanna
    Fuchssteiner, Harry
    Peters, Paul-Gerhard
    Reicht, Gerhard
    Moser, Gabriele
    Dejaco, Clemens
    Vogelsang, Harald
    Primas, Christian
    Novacek, Gottfried
    Miehsler, Wolfgang
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2021, 9 (01) : 72 - 81